BROWSE

Related Scientist

CN's photo.

CN
나노의학 연구단
more info

ITEM VIEW & DOWNLOAD

Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling

Cited 0 time in webofscience Cited 0 time in scopus
12 Viewed 0 Downloaded
Title
Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling
Author(s)
Su KyeomKim; Yu Heun Kim; Sewon Park; Seung-Woo Cho
Publication Date
2021-09-15
Journal
Acta Biomaterialia, v.132, pp.37 - 51
Publisher
Acta Materialia Inc
Abstract
© 2021As life expectancy improves and the number of people suffering from various diseases increases, the need for developing effective personalized disease models is rapidly rising. The development of organoid technology has led to better recapitulation of the in vivo environment of organs, and can overcome the constraints of existing disease models. However, for more precise disease modeling, engineering approaches such as microfluidics and biomaterials, that aid in mimicking human physiology, need to be integrated with the organoid models. In this review, we introduce key elements for disease modeling and recent engineering advances using both liver and lung organoids. Due to the importance of personalized medicine, we also emphasize patient-derived cancer organoid models and their engineering approaches. These organoid-based disease models combined with microfluidics, biomaterials, and co-culture systems will provide a powerful research platform for understanding disease mechanisms and developing precision medicine; enabling preclinical drug screening and drug development. Statement of significance: The development of organoid technology has led to better recapitulation of the in vivo environment of organs, and can overcome the constraints of existing disease models. However, for more precise disease modeling, engineering approaches such as microfluidics and biomaterials, that aid in mimicking human physiology, need to be integrated with the organoid models. In this review, we introduce liver, lung, and cancer organoids integrated with various engineering approaches as a novel platform for personalized disease modeling. These engineered organoid-based disease models will provide a powerful research platform for understanding disease mechanisms and developing precision medicine.
URI
https://pr.ibs.re.kr/handle/8788114/11066
DOI
10.1016/j.actbio.2021.03.002
ISSN
1742-7061
Appears in Collections:
Center for Nanomedicine (나노의학 연구단) > 1. Journal Papers (저널논문)
Files in This Item:
There are no files associated with this item.

qrcode

  • facebook

    twitter

  • Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse